Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:RAD

Rite Aid (RAD) Stock Price, News & Analysis

Rite Aid logo

About Rite Aid Stock (NYSE:RAD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.39
$1.89
52-Week Range
N/A
Volume
5,426 shs
Average Volume
4.16 million shs
Market Capitalization
$34.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rite Aid Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

RAD MarketRank™: 

Rite Aid scored higher than 1% of companies evaluated by MarketBeat, and ranked 213th out of 213 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Rite Aid.

  • Earnings Growth

    Earnings for Rite Aid are expected to grow in the coming year, from ($4.75) to ($3.35) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Rite Aid is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Rite Aid is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for RAD.
  • Dividend Yield

    Rite Aid does not currently pay a dividend.

  • Dividend Growth

    Rite Aid does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for RAD.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Rite Aid this week, compared to 6 articles on an average week.
  • Search Interest

    Only 2 people have searched for RAD on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Rite Aid insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.58% of the stock of Rite Aid is held by insiders.

  • Percentage Held by Institutions

    Only 34.47% of the stock of Rite Aid is held by institutions.

  • Read more about Rite Aid's insider trading history.
Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

RAD Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

RAD Stock Analysis - Frequently Asked Questions

Rite Aid Co. (NYSE:RAD) posted its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The business's revenue for the quarter was up .5% compared to the same quarter last year.

Rite Aid's stock reverse split on the morning of Monday, April 22nd 2019.The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

The following companies are subsidiaries of Rite Aid: Bartell Drugs, Envision Pharmaceutical, RediClinic, Health Dialog, Edgehill Drugs, PCS Health Systems, Harco, and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rite Aid investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
4/20/2023
Today
7/12/2025
Fiscal Year End
2/28/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NYSE:RAD
CIK
84129
Employees
47,000
Year Founded
1968

Profitability

EPS (Trailing Twelve Months)
($17.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$749.94 million
Net Margins
-3.99%
Pretax Margin
-4.02%
Return on Equity
N/A
Return on Assets
-1.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.32
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$24.09 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.36
Book Value
($11.35) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
56,700,000
Free Float
55,800,000
Market Cap
$34.71 million
Optionable
Optionable
Beta
1.25

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NYSE:RAD) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners